Catalyst Pharmaceuticals CPRX
CPRX
$31.49 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Catalyst Pharmaceuticals (CPRX) Total Non-Current Liabilities (2010 - 2026)

Updated

Catalyst Pharmaceuticals (CPRX) posted Total Non-Current Liabilities of $134.63 million for Q1 2026, up 17.8% from $114.33 million a year earlier but down 9.9% from the prior quarter.

Analysis

Catalyst Pharmaceuticals (CPRX) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Catalyst Pharmaceuticals' Total Non-Current Liabilities came in at $149.5 million, up 21.1% from FY2024.

  • Annual Total Non-Current Liabilities has increased for four consecutive years, with a four-year compound annual growth rate of 48.2% (FY2021 to FY2025).
  • In prior years, Catalyst Pharmaceuticals' Total Non-Current Liabilities was $123.46 million in FY2024 (+55.8%), $79.25 million in FY2023 (+29.6%), $61.15 million in FY2022 (+97.5%) and $30.96 million in FY2021.
  • Quarterly Total Non-Current Liabilities has run from a low of $30.96 million in Q4 2021 to a high of $149.5 million in Q4 2025 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities has increased in each of the last 11 quarters, with growth averaging 40.4% over the last eight quarters.
  • Across the past five years, year-over-year growth in Total Non-Current Liabilities ran from 17.8% in Q1 2026 to 97.5% in Q4 2022.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $149.5 million (Q4 2025), $131.2 million (Q3 2025) and $115.58 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Catalyst Pharmaceuticals 3.85 Bn 1.04 Bn 134.92 Mn 134.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 134.63 Mn
Dec 31, 2025 149.50 Mn
Sep 30, 2025 131.20 Mn
Jun 30, 2025 115.58 Mn
Mar 31, 2025 114.33 Mn
Dec 31, 2024 123.46 Mn
Sep 30, 2024 108.28 Mn
Jun 30, 2024 95.31 Mn
Mar 31, 2024 82.66 Mn
Dec 31, 2023 79.25 Mn
Sep 30, 2023 61.09 Mn
Jun 30, 2023 55.88 Mn
Mar 31, 2023 60.18 Mn
Dec 31, 2022 61.15 Mn
Sep 30, 2022 48.32 Mn
Dec 31, 2021 30.96 Mn
Dec 31, 2019 24.75 Mn
Jun 30, 2019 14.15 Mn
Mar 31, 2019 9.90 Mn
Dec 31, 2018 9.51 Mn
API Access

Catalyst Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CPRX&period=max&api_key=YOUR_API_KEY